Please Note: Blog posts are not selected, edited or screened by Seeking Alpha editors. International Stem Cell Corp., a California-based biotechnology company focused on therapeutic and research ...
Plans to seek FDA submission and approval for first-in-human trials in type 1 diabetes and stiff person syndrome targeted for early 2026 MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)-- Aditxt, Inc. (ADTX) ...
Researchers may have just found a way to restore normal blood glucose levels in a mouse model of type 1 diabetes, which could prove to be a promising solution for people with type 1 or type 2 diabetes ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback